Clinical Trial Update: Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a highly conformal, hypofractionated, focally dose-escalated radiotherapy approach after radical prostatectomy for prostate cancer; res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Cancer Of Prostate, Prostate Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2024-05-14